Covidence vs Rayyan
Rayyan scores 8.2 to Covidence's 6.8 among the systematic review platforms we rate, and is the better pick for 3 of the 5 kinds of buyer below.
Rayyan wins, 8.2 to 6.8
Covidence costs $339 a year, billed annually with no monthly option; Rayyan's cheapest paid plan is $8.33 a month, billed quarterly. Rayyan also has a mobile app and, on its Enterprise tier, an API, neither of which Covidence offers. Covidence answers back with automatic reference deduplication and a PRISMA flow diagram generated for every review, both included from its cheapest plan, plus support for six reference managers including RevMan and CRS for Cochrane style reviews, where Rayyan names none.
Pick Covidence if you need Cochrane style reference manager support built in.
Pick Rayyan if you want a mobile app and cheaper quarterly billing.
Best for
Who each one suits, decided on the criteria that matter to that buyer and the checked facts where the two differ.
- Answers a research question from the literature: Rayyan yes, Covidence no
- Answers show the passage they came from: Rayyan yes, Covidence no
- Ask questions of a paper: Rayyan yes, Covidence no
- API: Rayyan yes, Covidence no
- Mobile app: Rayyan yes, Covidence no
- Works in languages other than English: Rayyan yes, Covidence no
- But Covidence leads on works with Zotero, Mendeley, EndNote and others: EndNote, Zotero, RefWorks, Mendeley, RevMan, CRS against None
How they score
Both are scored the same way, against the other systematic review platforms we rate, from facts on each vendor's own pages. Rayyan leads on 4 of 6 criteria.
Where they differ
Every point where the two vendors' published facts disagree, with a link to where each fact was read. "Not published" means the vendor does not say either way.
Published by only one of them
Where they match (16)
Pricing, plan by plan
Every plan each vendor publishes, monthly and yearly where both are offered.
Covidence
Rayyan
For everything else about each tool, read the full Covidence review and Rayyan review.
Covidence vs Rayyan: common questions
Which is better, Covidence or Rayyan?
Rayyan scores 8.2 and Covidence 6.8 out of 10 among the systematic review platforms we rate. Rayyan is ahead on extraction and analysis, teams, access and privacy, pricing and finding papers. Covidence is ahead on citing and exports.
Is Covidence or Rayyan cheaper?
Covidence's cheapest paid plan is $339/year and Rayyan's is $8.33/mo (billed quarterly; no monthly plan exists). Compare what each plan includes below before going on price alone.
What can Rayyan do that Covidence cannot?
On the facts both vendors publish: answers show the passage they came from, ask questions of a paper, aPI, mobile app, works in languages other than English and answers a research question from the literature.